Rhythm Pharmaceuticals(MX:RYTM)
MX$1,860.00+266.46 (+16.72%)
MX:RYTM
Rhythm Pharmaceuticals ownership
MX$1,860.00
At close:+266.46 (+16.72%)
Rhythm Pharmaceuticals (RYTM) Ownership - Who Owns Rhythm Pharmaceuticals?
1 Followers
Rhythm Pharmaceuticals (RYTM) Ownership Overview
- 0.77% Insiders
- 33.28% Mutual Funds
- 1.65% Other Institutional Investors
- 17.03% ETFs
- 47.28% Public Companies and Individual Investors
The ownership structure of Rhythm Pharmaceuticals (MX:RYTM) stock is a mix of institutional, retail, and individual investors. Approximately 51.95% of the company’s stock is owned by Institutional Investors, 0.77% is owned by Insiders, and 47.28% is owned by Public Companies and Individual Investors.
The ownership structure of Rhythm Pharmaceuticals (MX:RYTM) stock is a mix of institutional, retail, and individual investors. Approximately 51.95% of the company’s stock is owned by Institutional Investors, 0.77% is owned by Insiders, and 47.28% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 18, 2026 | Christopher Paul German | $428,131 | |
| Mar 05, 2026 | Christopher Paul German | $502,790 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Peter Kolchinsky | 6,666,837 | Institution | 9.62% | 669,263,766 |
| BlackRock, Inc. | 6,156,902 | Institution | 8.88% | 618,072,921 |
| Vanguard | 5,935,728 | Institution | 8.56% | 595,869,927 |
| Felix Baker | 5,604,483 | Institution | 8.08% | 562,617,235 |
| Vanguard Index Funds | 5,370,730 | Institution | 7.75% | 539,151,473 |
| Theofanis Kolokotrones | 3,168,853 | Institution | 4.57% | 318,111,646 |
| Ishares | 3,055,192 | Institution | 4.41% | 306,701,559 |
| Primecap Odyssey Funds | 2,976,171 | Institution | 4.29% | 298,768,878 |
| Joseph Edelman | 2,586,295 | Institution | 3.73% | 259,630,396 |
| Smallcap World Fund Inc | 1,707,348 | Institution | 2.46% | 171,395,544 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 5,370,730 | Institution | 7.75% | 539,151,473 |
| Primecap Odyssey Funds | 2,976,171 | Institution | 4.29% | 298,768,878 |
| Smallcap World Fund Inc | 1,707,348 | Institution | 2.46% | 171,395,544 |
| Federated Hermes Equity Funds | 1,636,365 | Institution | 2.36% | 164,269,773 |
| Jpmorgan Trust Ii | 1,029,978 | Institution | 1.49% | 103,396,401 |
| T. Rowe Price New Horizons Fund, Inc. | 779,815 | Institution | 1.12% | 78,283,288 |
| Fidelity Concord Street Trust | 677,118 | Institution | 0.98% | 67,973,845 |
| Fidelity Salem Street Trust | 664,326 | Institution | 0.96% | 66,689,694 |
| Vanguard Explorer Fund | 559,749 | Institution | 0.81% | 56,191,523 |
| Fidelity Securities Fund | 525,660 | Institution | 0.76% | 52,769,430 |
FAQ
Who Owns Rhythm Pharmaceuticals (MX:RYTM)?
According to the latest TipRanks data, approximately 51.95% of the company's stock is held by institutional investors, 0.77% is held by insiders, and 47.28% is held by public companies and individual investors.
What percentage of Rhythm Pharmaceuticals (MX:RYTM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.95% of Rhythm Pharmaceuticals (MX:RYTM) stock is held by institutional investors: 33.28% by mutual funds, 17.03% by ETFs and 1.65% by other institutional investors.
What percentage of Rhythm Pharmaceuticals (MX:RYTM) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.28% of Rhythm Pharmaceuticals (MX:RYTM) stock is held by public companies and individual investors.
Who owns the most shares of Rhythm Pharmaceuticals (MX:RYTM)?
Peter Kolchinsky owns the most shares of Rhythm Pharmaceuticals (MX:RYTM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
